[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

This new weight loss drug ETF bets big on two of the industry’s leading players

[#item_full_content]While Novo Nordisk and Eli Lilly have soared in the past year, Roundhill Investments sees bigger…

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]